← All stocks

Personalis, Inc.

PSNL Net buying
CIK 0001527753 #2142 in the set updated 18 Sep 2026
Bought (120 mo)
$56.81M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$66.17M
$0.00 on a plan · $19.41M straight out of an exercise
Sold at will
$46.76M
123 of 156 sales
Net
−$9.37M
+$10.04M against sales at will

By person

21 insiders · 186 transactions
5.7×

Christopher Hall holds 5.7 times base salary in stock. $3.58M of shares against $618.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Christopher Hall last reported holding, valued at $15.15, the price Common Stock was last bought or sold at on the open market here, on 15 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Abingworth LLP
Former 10% Owner
$38.49M (8)
−$38.49M
3,753,340
3.51%
$56.86M
+1,890%
Lightspeed Venture Partners Select IV, L.P. entity
Affiliate of 10% Owner
$34.43M (6)
+$34.43M
4,047,716
3.79%
$61.32M
+106.7%
Tempus AI, Inc. entity
10% owner
$20.48M (13)
+$20.48M
13,039,067
12.21%
$197.54M
West John Stephen
President and CEO
$10.76M (12)
−$10.76M
622,444
0.5828%
$9.43M
−18.9%
Chen Richard
President and CMO
$8.13M (63) scheduled
−$8.13M
173,880
0.1628%
$2.63M
+343.8%
Hall Christopher M
Chief Executive Officer
$4.35M (7) scheduled
−$4.35M
235,986
0.2210%
$3.58M
+4.9%
Tachibana Aaron
CFO AND COO
$3.93M (48) scheduled
−$3.93M
198,833
0.1862%
$3.01M
LUDLUM KEN
Director
$1.19M (1)
$403.39K (2)
+$786.61K
113,506
0.1063%
$1.72M
+147.7%
RICCI PAUL
Director
$680.00K (2)
+$680.00K
20,000
0.0187%
$303.00K
Moore Stephen Michael
SVP and Chief Legal Officer
$104.64K (16)
−$104.64K
92,325
0.0864%
$1.40M
+45.4%
MYERS WOODROW A JR
Director
$16.70K (1)
+$16.70K
32,366
0.0303%
$490.34K
LIGHTSPEED VENTURE PARTNERS VIII LP entity
10% owner
1,958,726
1.83%
$29.67M
Ninth MDV Partners, L.L.C. entity
10% owner
127,504
0.1194%
$1.93M
Shoff Lonnie
Director
37,190
0.0348%
$563.43K
Bloom Olivia Kyusuk
Director
27,265
0.0255%
$413.06K
EASTHAM KARIN
Director
22,366
0.0209%
$338.84K
+756.9%
BOWMAN A BLAINE
Director
19,756
0.0185%
$299.30K
Colowick Alan
Director
13,506
0.0126%
$204.62K
Musil Clinton
Chief Business Officer
11,000
0.0103%
$166.65K
WIDDER KENNETH J
Director
6,250
0.0059%
$94.69K
MacQuitty Jonathan
Director
2,736
0.0026%
$41.45K
Insider
Date
Role
Action
Shares
Price
Amount
Chen Richard
15 Jul 2026
President and CMO
Sold after exercise
100,000
$15.15
$1.52M
Hall Christopher M
9 Jul 2026
Chief Executive Officer
Sold after exercise
100,000
$15.08
$1.51M
Tachibana Aaron
29 Jun 2026
CFO AND COO
Sold after exercise
4,982
$14.00
$69.75K
Hall Christopher M
26 Jun 2026
Chief Executive Officer
Sold after exercise
100,000
$13.15
$1.32M
Tachibana Aaron
26 Jun 2026
CFO AND COO
Sold after exercise
51,251
$13.18
$675.49K
Tachibana Aaron
4 Jun 2026
CFO AND COO
Sold after exercise
40,000
$12.01
$480.40K
Tachibana Aaron
29 May 2026
CFO AND COO
Sold after exercise
38,799
$11.58
$449.29K
Hall Christopher M
29 May 2026
Chief Executive Officer
Sold after exercise
80,091
$11.02
$882.60K
Hall Christopher M
28 May 2026
Chief Executive Officer
Sold after exercise
19,909
$11.02
$219.40K
Tachibana Aaron
22 Jan 2026
CFO AND COO
Sold after exercise
1,201
$11.50
$13.81K
Tachibana Aaron
25 Nov 2025
CFO AND COO
Sold after exercise
103,668
$10.78
$1.12M
West John Stephen
13 Apr 2022
President and CEO
Sold after exercise
64,430
no price
Chen Richard
6 Aug 2021
Chief Scientific Officer
Sold after exercise
4,436
$21.22
$94.13K
West John Stephen
8 Jul 2021
President and CEO
Sold after exercise
110,000
$22.54
$2.48M
West John Stephen
8 Jun 2021
President and CEO
Sold after exercise
9,950
$22.93
$228.15K
West John Stephen
8 Jun 2021
President and CEO
Sold after exercise
100,050
$22.38
$2.24M
Chen Richard
1 Apr 2021
Chief Scientific Officer
Sold after exercise
12,517
$25.69
$321.56K
Chen Richard
1 Apr 2021
Chief Scientific Officer
Sold after exercise
6,260
$25.96
$162.51K
Chen Richard
1 Apr 2021
Chief Scientific Officer
Sold after exercise
21,223
$25.61
$543.52K
Chen Richard
1 Feb 2021
Chief Scientific Officer
Sold after exercise
11,022
$38.80
$427.65K
Chen Richard
1 Feb 2021
Chief Scientific Officer
Sold after exercise
2,400
$38.12
$91.49K
Chen Richard
1 Feb 2021
Chief Scientific Officer
Sold after exercise
20,059
$38.83
$778.89K
Chen Richard
1 Feb 2021
Chief Scientific Officer
Sold after exercise
6,519
$38.19
$248.96K
Chen Richard
1 Dec 2020
Chief Scientific Officer
Sold after exercise
25,612
$28.14
$720.72K
Chen Richard
1 Dec 2020
Chief Scientific Officer
Sold after exercise
14,388
$27.75
$399.27K
Chen Richard
1 Oct 2020
Chief Scientific Officer
Sold after exercise
26,528
$22.26
$590.51K
Chen Richard
1 Oct 2020
Chief Scientific Officer
Sold after exercise
13,472
$21.67
$291.94K
Chen Richard
14 Aug 2020
Chief Scientific Officer
Sold after exercise
1,200
$20.47
$24.56K
Chen Richard
14 Aug 2020
Chief Scientific Officer
Sold after exercise
27,366
$20.17
$551.97K
Chen Richard
14 Aug 2020
Chief Scientific Officer
Sold after exercise
3,434
$19.76
$67.86K
Chen Richard
9 Mar 2020
Chief Scientific Officer
Sold after exercise
1,000
$7.84
$7.84K
Chen Richard
2 Mar 2020
Chief Scientific Officer
Sold after exercise
1,000
$8.76
$8.76K
Chen Richard
25 Feb 2020
Chief Scientific Officer
Sold after exercise
101,000
$8.77
$885.77K

What was left out

Form 4 filings counted 255
Amendments (4/A) skipped 4
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 33
Sales at will 123
Transactions with no price 1
Shares from compensation/vesting 26,539,491
Sales filed before the plan box existed 79
History held since 24 Jun 2019